NCT04032873

Brief Summary

This study evaluates the influence of cost information on decision-making for immobilization for treatment of distal radial buckle fractures. Half of the participants will receive cost information from an orthopaedic surgeon prior to making their decision for treatment, while the other half will receive cost information from another member of the study team after they had made their decision treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
129

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 31, 2017

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

July 23, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 25, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 9, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 9, 2019

Completed
Last Updated

February 3, 2021

Status Verified

February 1, 2021

Enrollment Period

2.4 years

First QC Date

July 23, 2019

Last Update Submit

February 1, 2021

Conditions

Keywords

Distal Radius FractureCostBuckle Fracture

Outcome Measures

Primary Outcomes (1)

  • Monetary Cost of Immobilization's Influence on Treatment Decisions

    The outcome measure will evaluate whether monetary cost influenced payers' decisions to choose one immobilization treatment over the other (splinting vs. casting).

    1 to 5 minutes

Secondary Outcomes (1)

  • Timing/Person Effect on Decision-Making

    1 to 5 minutes

Study Arms (2)

Provider Cost

OTHER

The subject will be given information about the cost of casting and splinting for treatment of the buckle fracture by the orthopaedic surgeon before the decision for immobilization has been made.

Other: Monetary Cost of Immobilization TreatmentsOther: PhysicianOther: Before Initial Treatment Decision

Research Team Cost

OTHER

The subject will be given information about the cost of casting and splinting for treatment of the buckle fracture by a member of the study team after the decision for immobilization has been made.

Other: Monetary Cost of Immobilization TreatmentsOther: Study TeamOther: After Initial Treatment Decision

Interventions

Information regarding the monetary cost of casting and splinting patient's buckle fracture to be presented to adult subject/payer.

Also known as: Cost Information
Provider CostResearch Team Cost

The monetary cost information is relayed by the patient's physician

Provider Cost

The monetary cost information is relayed by a member of the study team

Research Team Cost

Monetary cost information is relayed during the initial consult, before the treatment decision is made.

Also known as: Initial Consult
Provider Cost

Monetary cost information is relayed after the initial consult with the treating physician, after the treatment decision is made.

Also known as: Post-Consult
Research Team Cost

Eligibility Criteria

Age4 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Males or females ages 4 to 14 years with a buckle fracture for which they will be treated with a cast or a splint.
  • Parental/guardian permission (informed consent) and, if appropriate, child assent.
  • Parent of a child ages 4 to 14 years with a buckle fracture that requires treatment with either a cast or a splint.
  • Parental/guardian permission (informed consent).

You may not qualify if:

  • Non-English speaking subjects.
  • Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Wrist Fractures

Interventions

Physicians

Condition Hierarchy (Ancestors)

Wrist InjuriesArm InjuriesWounds and InjuriesFractures, Bone

Intervention Hierarchy (Ancestors)

Health PersonnelHealth Care Facilities Workforce and Services

Study Officials

  • John Todd R Lawrence, MD, PhD

    Children's Hospital of Philadelphia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2019

First Posted

July 25, 2019

Study Start

May 31, 2017

Primary Completion

October 9, 2019

Study Completion

October 9, 2019

Last Updated

February 3, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

The IPD will not be shared with researchers outside of the research team for this clinical trial.

Locations